On December 4, Sharon Bracken, Global President of Siemens Healthineers Diagnostics, along with Wang Haofeng, Head of Siemens Diagnostics China, led a delegation to visit Shanghai Jiao Tong University School of Medicine. They were warmly received by Chancellor Fan Xianqun, an academician of the Chinese Academy of Engineering, and Vice Chancellor Zheng Junke.
The visit began with a tour of the SJTUSM History Museum, where the guests learned about the institution’s establishment, its achievements in talent development, education, and medical services.
Following the tour, the two sides held a discussion session. Chancellor Fan Xianqun warmly welcomed Bracken and her delegation, highlighting Siemens Healthineers Diagnostics as one of the world’s largest clinical diagnostics companies with outstanding technological capabilities. He emphasized SJTUSM’s longstanding commitment to advancing medical technology through education and research and expressed his hope for enhanced mutual understanding and collaboration to drive medical innovation and development together.
President Bracken expressed her gratitude to Chancellor Fan and shared her desire to leverage the strengths of both sides, explore potential collaboration, and establish a long-term partnership in medical research and innovation.
The meeting was chaired by Vice Chancellor Zheng Junke. Xu Lin, Director of the International Affairs Office, presented an overview of SJTUSM, covering its faculty, academic programs, research innovations, and contributions to the medical field. Massie Mike, Head of the Laboratory Market for Siemens Diagnostics Laboratory Solutions Center, introduced Siemens Diagnostics’ core operations, focusing on three main business modules: central laboratory solutions, specialized laboratory solutions, and clinical point-of-care (POC) solutions. Wang Haofeng supplemented this by highlighting Siemens Diagnostics’ strengths and progress in innovative projects.
Participants from both sides engaged in an in-depth exchange on university-enterprise collaboration. Shen Baiyong, Vice President of Ruijin Hospital; Zhou Xiangtian, Director of the Science and Technology Development Office; Wang Xuefeng, Vice Dean of the School of Medical Technology and Director of the Clinical Laboratory at Ruijin Hospital; Li Min, Director of the Clinical Laboratory at Renji Hospital; and Zheng Yingxia, Director of the Clinical Laboratory at Xinhua Hospital, shared insights on scientific research and talent cultivation. Discussions included exploring the potential of leveraging Siemens Diagnostics’ advanced AI technologies to develop medical diagnostic innovations, co-developing new disease biomarkers, and industrializing such advancements.
President Bracken responded positively to these suggestions, expressing interest in international medical education collaboration, early-stage clinical development of new technologies, clinical registration of innovative projects, AI applications in diagnostics, joint biomarker research, and building shared medical laboratory platforms.
In his concluding remarks, Chancellor Fan emphasized that SJTUSM is equipped with extensive medical and research resources, including 13 affiliated hospitals with leading national reputations, five national medical centers, and two national key laboratories. He expressed hope that this meeting would serve as a strong starting point for communication and collaboration, enabling the two sides to complement each other’s strengths and share resources, ultimately driving medical innovation and technological progress for the benefit of global healthcare.
Siemens Healthineers Diagnostics is one of the world’s largest clinical diagnostics companies, committed to technological innovation. Operating in over 70 countries, the company collaborates with more than 90% of the world’s leading healthcare institutions.
